316 related articles for article (PubMed ID: 1724648)
1. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
[TBL] [Abstract][Full Text] [Related]
2. [Effects of propiverine hydrochloride (propiverine) on the muscarinic receptor binding affinity in guinea pig tissues and on salivation in conscious dogs].
Nagao M; Kaneko S; Hirota T; Isogai M; Shimizu H
Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):157-66. PubMed ID: 10347840
[TBL] [Abstract][Full Text] [Related]
3. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.
Noronha-Blob L; Kachur JF
J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995
[TBL] [Abstract][Full Text] [Related]
4. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
[TBL] [Abstract][Full Text] [Related]
5. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimuscarinic activity of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2-propanones and related compounds.
Kaiser C; Audia VH; Carter JP; McPherson DW; Waid PP; Lowe VC; Noronha-Blob L
J Med Chem; 1993 Mar; 36(5):610-6. PubMed ID: 8496940
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and muscarinic receptors affinity of a series of antagonist bivalent ligands.
Piergentili A; Quaglia W; Tayebati SK; Paparelli F; Malmusi L; Brasili L
Farmaco; 1994 Feb; 49(2):83-7. PubMed ID: 7516166
[TBL] [Abstract][Full Text] [Related]
10. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.
Fuder H; Meincke M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):591-5. PubMed ID: 7689704
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
12. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G
Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the presence of regional differences in the subtype specificity of muscarinic receptors in rabbit lower urinary tract.
Mutoh S; Latifpour J; Saito M; Weiss RM
J Urol; 1997 Feb; 157(2):717-21. PubMed ID: 8996405
[TBL] [Abstract][Full Text] [Related]
14. Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine.
Take K; Okumura K; Tsubaki K; Taniguchi K; Terai T; Shiokawa Y
Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1858-64. PubMed ID: 8904812
[TBL] [Abstract][Full Text] [Related]
15. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
[TBL] [Abstract][Full Text] [Related]
16. Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus.
Dörje F; Friebe T; Tacke R; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):284-9. PubMed ID: 2280796
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
18. Characterization of muscarinic receptors mediating the contraction of the urinary detrusor muscle in cynomolgus monkeys and guinea pigs.
Lai FM; Cobuzzi A; Spinelli W
Life Sci; 1998; 62(13):1179-86. PubMed ID: 9519799
[TBL] [Abstract][Full Text] [Related]
19. Conditional involvement of muscarinic M1 receptors in vagally mediated contraction of guinea-pig bronchi.
ten Berge RE; Roffel AF; Zaagsma J
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):173-8. PubMed ID: 7477440
[TBL] [Abstract][Full Text] [Related]
20. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
